Conference abstract · 2015
Conference abstract
Postmenopausal osteoporosis
University of Toledo, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Osteoporosis is more common in postmenopausal women than in men of similar age. In those women who are not treated for menopause are more likely to develop bone loss and an increase in minimal trauma fractures. The current recommendations are that bone mineral density (BMD) should not be assessed before age 65 but one or two programs recommend an age 60 for the first Dual Energy X-ray Absorptiometry (DXA). Women who have additional post-menopause medical conditions and/ or medications may have increased risk of minimal trauma fractures before age 60. DXA studies should be accompanied by laboratory studies that include serum calcium, serum creatinine, and 25 hydroxyvitamin D, as well 24 hour urine collection for calcium, creatinine, sodium, uric acid, and oxalate. Management is dependent on the bone density and biochemistry. The biochemistry includes markers of bone resorption i.e., C-terminal telopeptide of type 1 collagen (CTX), and bone formation i.e., bone alkaline phosphatase (B-ALP), C-terminal propeptide of type 1 procollagen (P1CP) and N-terminal propeptide of type 1 procollagen (P1NP). Regrettably the majority of DXA studies are performed and reported by bone density technicians and clinicians who have not been appropriately trained in the conduct and reporting of DXA and therapy is often incorrect. Once diagnosed as osteoporosis, there are several anti-resorption products that have been approved by the FDA or are in progress and teriparatide has been approved for stimulation of bone formation. Once a diagnosis of osteoporosis and appropriate therapy has been established, measurement of biochemical markers should be obtained at 6 monthly intervals until the levels are stable. If bone density is stable for five years, the therapy can be discontinued and biochemistry analyzed at 6-12 monthly intervals. More recent studies in progress include high resolution measurement of the distal radius and tibia using either high resolution Magnetic Imaging (hrMRI) or high resolution Dual energy X-ray Absorptiometry (hrDXA). hrDXA is also being study in the spine and proximal femur. These studies provide improved evaluation of skeletal health. Details of the above aspects of skeletal studies are shown in the accompanying illustrations and images.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Nov 2015
Postmenopausal osteoporosis
Research article · 9 Jun 2015
Effects of Raloxifene Hydrochloride on Bone Mineral Density and Serum Lipids in Kuwaiti Postmenopausal Women with Osteoporosis
Review article · 20 Mar 2015
Physical treatment in postmenopausal osteoporosis? a review of research
Commentary · 20 Mar 2025
Postmenopausal Osteoporosis: Causes, Mechanisms, Risks, Diagnosis, Treatment, and Prevention Guide
More from this journal
The newest in Andrology & Gynecology: Current Research.
Research article · 30 Jun 2026
NOA-SERA: Combined Autologous Progenitor Cells and Platelet-Derived Growth Factors for Male Factor Infertility Due to Non-Obstructive Azoospermia (NOA) and Severe Oligoasthenoteratozoospermia (OATS)-A Case Series
Editorial · 28 Mar 2025
Advances in Male Infertility Diagnosis and Treatment: A Contemporary Overview
Editorial · 28 Mar 2025
Advances in Urogenital Surgery: Minimally Invasive Techniques in Andrology and Gynecology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAndrology & Gynecology: Current Research
- SubjectNephrology & Urology
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Michael Kleerekoper”

